Nanosonics Limited (ASX:NAN) is an Australian infection prevention company that has successfully developed a unique automated disinfection technology, trophon EPR, which is the global standard of care for ultrasound probe disinfection. The company also manufactures and distributes other related technologies. Nanosonics is based in Sydney with sales offices in the US and Europe. Nanosonics' operations are focused on the development, manufacturing, and sale of the trophon EPR ultrasound probe disinfector and its associated consumables and accessories. The company also invests in research and development to commercialize new infection control and decontamination products and related technologies.
What are the products and/or services of Nanosonics?
Overview of Nanosonics offerings
trophon® device: Automated disinfection technology for ultrasound probes, the global standard of care for high level disinfection of ultrasound probes.
Expanding global reach of trophon® device: Expanding the global reach of the trophon® device to help more healthcare providers protect patients from infection.
Developing new disinfection technologies for other medical devices: Developing new disinfection technologies for other medical devices, such as endoscopes and medical instruments.
Investing in research and development: Investing in research and development to improve infection prevention practices and develop new disinfection technologies.
Automated disinfection solutions for medical devices: Leading provider of automated disinfection solutions for medical devices, helping healthcare providers protect patients from infection.
Superior returns to shareholders: Delivering superior returns to shareholders through strong financial performance and innovation.
